Crescendus
TM
DRUG DISCOVERY & DEVELOPMENT
Drug Discovery & Development Services
Technology Assessments
Business Development
Project Management
Licensing & Partnering Opportunities
R&D, Prototyping, Pilot Plants & EPC Sourcing
Supply Chain Recommendations
Operations Management
R&D, Engineering & Product Development Roadmaps
DRUG DISCOVERY & DEVELOPMENT FOCUS
Discovery & Validation
High Throughput Screening
-
Combinatorial Chemistry
-
Genomic, Proteomic, Glycomic, Tissues & Cell Assays
-
SNP/Mutation Analysis
-
Sequencing
Informatics
-
Bioinformatics
-
Cheminformatics
-
Structure based design
-
Lab Informatics (LIMS), Electronic Notebooks (ELN)
-
Text, Image, Scientific (e.g. chemical structures, biological) search and workflows
Identification & Validation of Disease Models and Mechanism of Action
Preclinical/Phase O
-
PK/PD
-
Toxicity
-
Initial safety studies
-
Animal models/results
-
Imaging studies
Reagents Development
-
Antibodies
-
Nucleic Acids
-
Peptides/Fragments
-
Signal amplification probes
-
Tissues
-
Biomarkers
Clinical Development
Phase 1- 4 Clinical Trials
-
Small molecules, Biologics
-
Trial Design & Selection of statistically significant end points
-
Safety, Efficacy, Risk-Benefit analysis
-
Recruitment
-
Analytical testing
-
Data Collection & Analysis
-
Adverse events
-
Post marketing surveillance/long term studies
Informatics
-
Electronic Data Capture (EDC), CRF, Regulatory submissions
-
Database Design, Integration, Reporting
-
Biostatistics
-
Data Analytics & Trial Insights, including advanced visualization tools
Chemistry, Manufacturing & Controls
-
Quality by Design techniques (QbD)
-
Process Analytical Technologies (PAT)
-
API development, variability analysis
-
Formulations
-
Stability/Release analysis
-
Complex Biologics Processes- e.g. Cell Lines, High volume fermentation systems
-
Risk analysis
Companion Biomarker-Drug Development
-
Linking in-vivo or in-vitro biomarkers with pharmaceutical or biotech drugs for personalized therapy applications and minimizing side effects
-
Co-development trial design and analysis (drug and diagnostic product)
Generics
-
Dosing
-
Bioequivalence studies
-
Safety analysis & adverse events
Regulations & Evidence based Outcomes
Regulatory
-
IND
-
NDA
-
ANDA
-
BLA
-
cGMP
-
Marketing/Labeling
-
International audits of supply chain & global manufacturing facilities
Evidence based Medicine/Health Outcomes
-
QALY
-
Drug comparision and effectiveness analysis
-
Registries, Database review & analysis